首页 > 最新文献

Schweizerische medizinische Wochenschrift最新文献

英文 中文
[CVID (common variable immunodeficiency): heterogeneous clinical manifestation of the commonest symptomatic primary immunodeficiency disease]. [CVID(共同可变免疫缺陷):最常见的症状性原发性免疫缺陷疾病的异质性临床表现]。
H Pfluger, A Helbling, C Mordasini, W J Pichler

Common variable immunodeficiency is the most common symptomatic primary immunodeficiency disease. The patients typically present with a long history of respiratory tract infections, sometimes sarcoid-like lesions and in rare cases boils. Heterogeneity of initial clinical manifestations as well as insufficient knowledge of the syndrome often delay the diagnosis. However, early therapy is important to reduce infections and in particular the development of bronchiectasis. Documenting 19 cases, we discuss initial clinical manifestations, some clinical complications, diagnostic procedures and therapeutic management.

常见变异性免疫缺陷是最常见的症状性原发性免疫缺陷疾病。患者通常表现为呼吸道感染的长期病史,有时出现结节样病变,在极少数情况下出现疖子。初始临床表现的异质性以及对该综合征的认识不足往往会延误诊断。然而,早期治疗是重要的,以减少感染,特别是支气管扩张的发展。我们记录了19例病例,讨论了最初的临床表现、一些临床并发症、诊断方法和治疗管理。
{"title":"[CVID (common variable immunodeficiency): heterogeneous clinical manifestation of the commonest symptomatic primary immunodeficiency disease].","authors":"H Pfluger,&nbsp;A Helbling,&nbsp;C Mordasini,&nbsp;W J Pichler","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Common variable immunodeficiency is the most common symptomatic primary immunodeficiency disease. The patients typically present with a long history of respiratory tract infections, sometimes sarcoid-like lesions and in rare cases boils. Heterogeneity of initial clinical manifestations as well as insufficient knowledge of the syndrome often delay the diagnosis. However, early therapy is important to reduce infections and in particular the development of bronchiectasis. Documenting 19 cases, we discuss initial clinical manifestations, some clinical complications, diagnostic procedures and therapeutic management.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21924166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rendu-Osler-Weber disease]. (Rendu-Osler-Weber疾病)。
N Halkic, S Zeini, K Hachemane, L Henchoz
{"title":"[Rendu-Osler-Weber disease].","authors":"N Halkic,&nbsp;S Zeini,&nbsp;K Hachemane,&nbsp;L Henchoz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21924171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neurogenic voiding disorders. Current status of diagnosis and therapy]. 神经性排尿障碍。诊断和治疗的现状]。
B Schürch

Treatment of the neurogenic voiding disorders which occur after spinal cord injury represents one of the most important challenges of rehabilitation. Inadequate management of neurogenic voiding disorders, especially of urinary incontinence, results in impaired quality of life. Moreover, inadequately treated neurogenic voiding disorders may result in medium and long-term renal complications and even death. Treatment of neurogenic disorders, whatever their origin (spinal cord injury, multiple sclerosis, Parkinson's disease), must take into account the gravity of the neurological disease, the potential risks for the upper urinary tract and the expected quality of life. Therefore, each patient must be considered as a separate entity and treated individually. Recent progress in the comprehension of the neurophysiology of the lower urinary tract and the neurophysiopathology of the neurogenic voiding disorders has been followed by the development of new diagnostic and therapeutic tools aimed at improving the patients' health and quality of life.

脊髓损伤后发生的神经源性排尿障碍的治疗是康复中最重要的挑战之一。神经源性排尿障碍,特别是尿失禁管理不当,导致生活质量受损。此外,治疗不当的神经源性排尿障碍可能导致中长期肾脏并发症甚至死亡。神经源性疾病的治疗,无论其起源如何(脊髓损伤、多发性硬化症、帕金森病),都必须考虑到神经疾病的严重性、对上尿路的潜在风险和预期的生活质量。因此,每个病人必须被视为一个独立的实体,并单独治疗。随着对下尿路神经生理学和神经源性排尿障碍的神经生理病理学的理解的最新进展,新的诊断和治疗工具的发展旨在改善患者的健康和生活质量。
{"title":"[Neurogenic voiding disorders. Current status of diagnosis and therapy].","authors":"B Schürch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Treatment of the neurogenic voiding disorders which occur after spinal cord injury represents one of the most important challenges of rehabilitation. Inadequate management of neurogenic voiding disorders, especially of urinary incontinence, results in impaired quality of life. Moreover, inadequately treated neurogenic voiding disorders may result in medium and long-term renal complications and even death. Treatment of neurogenic disorders, whatever their origin (spinal cord injury, multiple sclerosis, Parkinson's disease), must take into account the gravity of the neurological disease, the potential risks for the upper urinary tract and the expected quality of life. Therefore, each patient must be considered as a separate entity and treated individually. Recent progress in the comprehension of the neurophysiology of the lower urinary tract and the neurophysiopathology of the neurogenic voiding disorders has been followed by the development of new diagnostic and therapeutic tools aimed at improving the patients' health and quality of life.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21924170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pediatric kidney transplantation and living donors--invaluable by virtue of necessity]. [儿童肾移植和活体供体——因其必要性而无价]。
E Leumann, P Goetschel, T J Neuhaus, P M Ambühl, D Candinas

Unlabelled: Renal transplantation is the treatment of choice for paediatric patients with end-stage renal failure. Living donor transplantation (LDT) has become an important therapeutic option due to the shortage of cadaver donors and increasingly long waiting times.

Methods: Between 1992 and 1999, a total of 48 paediatric and adolescent patients underwent renal transplantation in Zurich. Of these, 21 patients (44%) received a kidney from a living related donor. 11 patients had been dialysed before LDT over a period of 0.2-5.7 years (median 0.6), and 10 were transplanted preemptively. Triple immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil (MMF; since 1998), and prednisone. The observation period was 0.5-7.3 years (median 2).

Results: Recipients were 2-18 (median 10.5) years old at transplantation. One third had either a congenital malformation, an inherited disease, or an acquired disorder. One patient died of an associated cardiac disease at 4 months with functioning graft, and one functional graft loss occurred after 2.8 years. 9 patients were switched from cyclosporine to tacrolimus, 7 for biopsy-proven rejection and 2 for cosmetic reasons (hypertrichosis). No antibody preparations were used. Median glomerular filtration rate (51Cr-EDTA), measured after one year in 11 donor/recipients, was 64 (55-95) and 54 (32-82) ml/min/1.73 m2, respectively. The most recent estimated renal function (Schwartz formula) of 19 functioning grafts was 37-79 ml/min/1.73 m2 (median 63). Median body height of 16 patients with no associated extrarenal disease was -0.9 SDS (standard deviation score); the remaining 3--with serious extra-renal disease--were considerably growth retarded. Main complications were reversible rejection episodes in 19 (90%), arterial hypertension (16), CMV disease (2) and asymptomatic CMV infection (3), pyelonephritis (3), and recurrence of the primary renal disease, seizures, diabetes mellitus and non-compliance (one each). Actuarial patient and graft survival (Kaplan-Meier) after 3 years was 95 and 83% respectively. This was not statistically different from the cadaveric donor group (n = 27) with 100 and 80% survival respectively. Overall rehabilitation was excellent. The donors were 12 mothers, 8 fathers and one grandmother aged 31 to 50 (median 39) years; none of them experienced serious postoperative problems.

Conclusions: The paediatric transplantation programme would no longer be feasible in Switzerland without LDT. The results are very encouraging; preemptive transplantation makes it possible to avoid dialysis in half of the patients. The risk for the donor is small, and careful evaluation without putting pressure on the family is essential.

未标记:肾移植是终末期肾衰竭患儿的首选治疗方法。由于尸体供体短缺和等待时间越来越长,活体供体移植(LDT)已成为一种重要的治疗选择。方法:1992年至1999年间,苏黎世共有48例儿童和青少年患者接受了肾移植。其中,21名患者(44%)接受了来自活体亲属供体的肾脏。11例患者在LDT前透析0.2-5.7年(中位0.6年),10例患者提前移植。三重免疫抑制包括环孢素A、硫唑嘌呤或霉酚酸酯(MMF);自1998年以来)和强的松。观察时间0.5 ~ 7.3年(中位2年)。结果:移植时受者年龄2 ~ 18岁(中位10.5岁)。三分之一的人患有先天性畸形、遗传性疾病或后天疾病。1例患者在移植后4个月死于相关心脏病,1例移植后2.8年发生功能丧失。9例患者从环孢素转为他克莫司,7例为活检证实的排斥反应,2例为美容原因(多毛症)。未使用抗体制剂。11名供体/受体一年后测量的中位肾小球滤过率(51Cr-EDTA)分别为64(55-95)和54 (32-82)ml/min/1.73 m2。19例功能性移植物的最新估计肾功能(Schwartz公式)为37-79 ml/min/1.73 m2(中位数63)。16例无相关肾外疾病患者的中位身高为-0.9 SDS(标准差评分);其余3名患有严重的肾外疾病,发育严重迟缓。主要并发症为可逆性排斥反应19例(90%),动脉高血压16例,巨细胞病毒病2例,无症状巨细胞病毒感染3例,肾盂肾炎3例,原发肾病复发、癫痫发作、糖尿病和不依从性各1例。3年后精算患者和移植物存活率(Kaplan-Meier)分别为95%和83%。这与尸体供体组(n = 27)的存活率(分别为100%和80%)没有统计学差异。整体康复情况良好。捐赠者为12位母亲、8位父亲和1位祖母,年龄31 ~ 50岁(中位39岁);他们都没有出现严重的术后问题。结论:在瑞士,如果没有LDT,儿科移植计划将不再可行。结果非常令人鼓舞;先发制人的移植使一半的患者可以避免透析。捐赠者的风险很小,在不给家庭施加压力的情况下进行仔细评估是至关重要的。
{"title":"[Pediatric kidney transplantation and living donors--invaluable by virtue of necessity].","authors":"E Leumann,&nbsp;P Goetschel,&nbsp;T J Neuhaus,&nbsp;P M Ambühl,&nbsp;D Candinas","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>Renal transplantation is the treatment of choice for paediatric patients with end-stage renal failure. Living donor transplantation (LDT) has become an important therapeutic option due to the shortage of cadaver donors and increasingly long waiting times.</p><p><strong>Methods: </strong>Between 1992 and 1999, a total of 48 paediatric and adolescent patients underwent renal transplantation in Zurich. Of these, 21 patients (44%) received a kidney from a living related donor. 11 patients had been dialysed before LDT over a period of 0.2-5.7 years (median 0.6), and 10 were transplanted preemptively. Triple immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil (MMF; since 1998), and prednisone. The observation period was 0.5-7.3 years (median 2).</p><p><strong>Results: </strong>Recipients were 2-18 (median 10.5) years old at transplantation. One third had either a congenital malformation, an inherited disease, or an acquired disorder. One patient died of an associated cardiac disease at 4 months with functioning graft, and one functional graft loss occurred after 2.8 years. 9 patients were switched from cyclosporine to tacrolimus, 7 for biopsy-proven rejection and 2 for cosmetic reasons (hypertrichosis). No antibody preparations were used. Median glomerular filtration rate (51Cr-EDTA), measured after one year in 11 donor/recipients, was 64 (55-95) and 54 (32-82) ml/min/1.73 m2, respectively. The most recent estimated renal function (Schwartz formula) of 19 functioning grafts was 37-79 ml/min/1.73 m2 (median 63). Median body height of 16 patients with no associated extrarenal disease was -0.9 SDS (standard deviation score); the remaining 3--with serious extra-renal disease--were considerably growth retarded. Main complications were reversible rejection episodes in 19 (90%), arterial hypertension (16), CMV disease (2) and asymptomatic CMV infection (3), pyelonephritis (3), and recurrence of the primary renal disease, seizures, diabetes mellitus and non-compliance (one each). Actuarial patient and graft survival (Kaplan-Meier) after 3 years was 95 and 83% respectively. This was not statistically different from the cadaveric donor group (n = 27) with 100 and 80% survival respectively. Overall rehabilitation was excellent. The donors were 12 mothers, 8 fathers and one grandmother aged 31 to 50 (median 39) years; none of them experienced serious postoperative problems.</p><p><strong>Conclusions: </strong>The paediatric transplantation programme would no longer be feasible in Switzerland without LDT. The results are very encouraging; preemptive transplantation makes it possible to avoid dialysis in half of the patients. The risk for the donor is small, and careful evaluation without putting pressure on the family is essential.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21924240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Amiodarone-induced thyrotoxicosis]. 可引起胺碘酮诱发(甲状腺毒症)。
C Kaufmann, T A Cron, C Meier, J J Staub, M Oberholzer, S Osswald

Amiodarone is the most important drug in the treatment of ventricular arrhythmias and is widely used for atrial fibrillation. Thyrotoxicosis, a classical side effect, was thought to be iodine induced, but recent evidence suggests that other mechanisms play an important role (toxic effect on thyreocytes, immunological effects). Thyrotoxicosis due to amiodarone is difficult to treat and is further complicated by the pro-arrhythmic potential of thyrotoxicosis and the fading antiarrhythmic effect after amiodarone withdrawal. The mechanism, diagnosis and therapy of amiodarone-induced thyrotoxicosis are discussed in the light of the available literature.

胺碘酮是治疗室性心律失常最重要的药物,广泛用于房颤治疗。甲状腺毒症,一种典型的副作用,被认为是碘诱导的,但最近的证据表明,其他机制起重要作用(对甲状腺细胞的毒性作用,免疫作用)。胺碘酮引起的甲状腺毒症治疗困难,且因甲状腺毒症的促心律失常潜能和胺碘酮停药后抗心律失常作用减弱而进一步复杂化。本文结合文献对胺碘酮致甲状腺毒症的发病机制、诊断及治疗进行了探讨。
{"title":"[Amiodarone-induced thyrotoxicosis].","authors":"C Kaufmann,&nbsp;T A Cron,&nbsp;C Meier,&nbsp;J J Staub,&nbsp;M Oberholzer,&nbsp;S Osswald","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Amiodarone is the most important drug in the treatment of ventricular arrhythmias and is widely used for atrial fibrillation. Thyrotoxicosis, a classical side effect, was thought to be iodine induced, but recent evidence suggests that other mechanisms play an important role (toxic effect on thyreocytes, immunological effects). Thyrotoxicosis due to amiodarone is difficult to treat and is further complicated by the pro-arrhythmic potential of thyrotoxicosis and the fading antiarrhythmic effect after amiodarone withdrawal. The mechanism, diagnosis and therapy of amiodarone-induced thyrotoxicosis are discussed in the light of the available literature.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21924169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant cell arteritis "causing" AA-amyloidosis with rapid renal failure. 巨细胞动脉炎“引起”aa -淀粉样变伴快速肾功能衰竭。
F Strasser, S Hailemariam, T Weinreich, R Speich, F Salomon

Giant cell arteritis (GCA) is a systemic vasculitic disease, which in very rare cases causes inflammatory complications such as secondary amyloidosis. We describe a well-documented case, with a clinically mild course, of biopsyproven giant cell arteritis as the only apparent cause of systemic AA-Amyloidosis. The deterioration in renal function due to amyloid deposition occurred rapidly and only a few months after manifestation of giant cell arteritis and was not reversible by steroid treatment. The renal arteries were normal and there was no glomerulonephritis due to giant cell arteritis. This unique case demonstrates that giant cell arteritis with a mild clinical course is closely associated with early-onset severe secondary amyloidosis.

巨细胞动脉炎(GCA)是一种全身性血管疾病,在极少数情况下会引起继发性淀粉样变性等炎症并发症。我们描述了一个有充分证据的病例,临床病程轻微,活检证实巨细胞动脉炎是系统性aa -淀粉样变的唯一明显原因。由于淀粉样蛋白沉积引起的肾功能恶化在巨细胞动脉炎表现后几个月内迅速发生,并且不能通过类固醇治疗逆转。肾动脉正常,未见巨细胞动脉炎所致肾小球肾炎。这个独特的病例表明,临床病程轻微的巨细胞动脉炎与早发性严重继发性淀粉样变性密切相关。
{"title":"Giant cell arteritis \"causing\" AA-amyloidosis with rapid renal failure.","authors":"F Strasser,&nbsp;S Hailemariam,&nbsp;T Weinreich,&nbsp;R Speich,&nbsp;F Salomon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Giant cell arteritis (GCA) is a systemic vasculitic disease, which in very rare cases causes inflammatory complications such as secondary amyloidosis. We describe a well-documented case, with a clinically mild course, of biopsyproven giant cell arteritis as the only apparent cause of systemic AA-Amyloidosis. The deterioration in renal function due to amyloid deposition occurred rapidly and only a few months after manifestation of giant cell arteritis and was not reversible by steroid treatment. The renal arteries were normal and there was no glomerulonephritis due to giant cell arteritis. This unique case demonstrates that giant cell arteritis with a mild clinical course is closely associated with early-onset severe secondary amyloidosis.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21924168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathophysiology of brain insult. Therapeutic implications with the Lund Concept. 脑损伤的病理生理学。隆德概念的治疗意义。
P O Grände

This paper describes some major implications of brain insult following trauma or intracerebral haemorrhage for the development of brain oedema and compromised microcirculation. Secondary insults such as an increase in intracranial pressure and development of contusion and penumbra zone areas, as well as their bearing on outcome, are discussed. A therapeutic protocol is presented which aims at keeping intracranial volume within acceptable limits by counteraction of interstitial brain oedema, reduction in intracerebral blood volume, and improvement of microcirculation around contusions. This ICP-targeted therapy, called the "Lund Concept", for treatment of severe head injury has resulted in marked reduction in mortality following brain trauma.

本文描述了创伤或脑出血后脑损伤对脑水肿和微循环受损发展的一些主要影响。继发性损伤,如颅内压的增加和挫伤和半暗带区域的发展,以及他们对结果的影响,进行了讨论。提出了一种治疗方案,旨在通过对抗间质性脑水肿,减少脑内血容量和改善挫伤周围微循环,将颅内容量保持在可接受的范围内。这种以icp为目标的治疗,被称为“隆德概念”,用于治疗严重头部损伤,显著降低了脑外伤后的死亡率。
{"title":"Pathophysiology of brain insult. Therapeutic implications with the Lund Concept.","authors":"P O Grände","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This paper describes some major implications of brain insult following trauma or intracerebral haemorrhage for the development of brain oedema and compromised microcirculation. Secondary insults such as an increase in intracranial pressure and development of contusion and penumbra zone areas, as well as their bearing on outcome, are discussed. A therapeutic protocol is presented which aims at keeping intracranial volume within acceptable limits by counteraction of interstitial brain oedema, reduction in intracerebral blood volume, and improvement of microcirculation around contusions. This ICP-targeted therapy, called the \"Lund Concept\", for treatment of severe head injury has resulted in marked reduction in mortality following brain trauma.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21917926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human-computer interactions: can computers improve the way doctors work? 人机交互:计算机能改善医生的工作方式吗?
C S Garrard

As medicine becomes more complex and the knowledge base expands, the integration of computer systems into clinical practice would appear to be an inescapable necessity rather than an option. The issues of security and reliability have largely been solved by industrial and business applications of computer technology. The larger challenge lies in designing convenient, efficient and acceptable interfaces between the clinician and computer for data input and presentation. In the future, decision making algorithms are likely to assist the clinician in diagnosis and management to a degree that should significantly improve clinical effectiveness.

随着医学变得越来越复杂,知识库扩大,将计算机系统集成到临床实践中似乎是一种不可避免的必要性,而不是一种选择。计算机技术的工业和商业应用在很大程度上解决了安全性和可靠性问题。更大的挑战在于在临床医生和计算机之间设计方便、高效和可接受的接口,用于数据输入和显示。在未来,决策算法可能会在一定程度上协助临床医生进行诊断和管理,从而显著提高临床疗效。
{"title":"Human-computer interactions: can computers improve the way doctors work?","authors":"C S Garrard","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>As medicine becomes more complex and the knowledge base expands, the integration of computer systems into clinical practice would appear to be an inescapable necessity rather than an option. The issues of security and reliability have largely been solved by industrial and business applications of computer technology. The larger challenge lies in designing convenient, efficient and acceptable interfaces between the clinician and computer for data input and presentation. In the future, decision making algorithms are likely to assist the clinician in diagnosis and management to a degree that should significantly improve clinical effectiveness.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21916779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rational utilization of antibiotics in critically ill children]. 危重患儿抗菌药物的合理应用
J E Fischer, M Ramser, S Altermatt, D Nadal, K Waldvogel

Background: The high risks associated with untreated infection in critically ill newborns or children lower the threshold for prescription of antibiotic treatment. Inappropriate use of antibiotic therapy promotes the emergence of resistant strains. This study had three aims: to identify sources of inappropriate antibiotic utilisation, to develop revised guidelines and to implement changes.

Methods: An observational study was performed in a tertiary, multidisciplinary, neonatal and paediatric intensive care unit (PICU) of a university teaching hospital during a 7-month period (456 admissions). Guidelines addressing one of the identified sources of inappropriate utilisation (prophylaxis following surgery) were developed according to published evidence and implemented, and the effect on prescription patterns was assessed during a second observation period.

Results: Patients received systemic antibiotics during 54.6% of all hospitalisation days. Antibiotics prescribed for suspected or proven infection were often continued 1-2 days beyond the intended duration. Prophylaxis accounted for 28% of all systemic antibiotics given, and postsurgical prophylaxis accounted for 14.6% of all exposure days. The literature search revealed little evidence to support this practice. After new guidelines were introduced with the aim of restricting surgical prophylaxis to a single dose prior to surgery, the rate of postsurgical prophylaxis dropped from 14.6 to 11.2% of all exposure days, accompanied by a significant decline in the overall exposure rate from 54.6 to 50.2% of all hospitalisation days.

Conclusion: Several sources of inappropriate antibiotic utilisation were identified. These include failure to discontinue treatment and prolonged prophylaxis after surgery. Implementation of new guidelines reduced antibiotic utilisation.

背景:危重新生儿或儿童未经治疗感染相关的高风险降低了抗生素治疗处方的门槛。不适当使用抗生素治疗促进耐药菌株的出现。这项研究有三个目的:确定不适当抗生素使用的来源,制定修订指南并实施变更。方法:在一所大学教学医院的三级、多学科、新生儿和儿科重症监护室(PICU)进行了一项为期7个月的观察性研究(456例入院)。针对已确定的不适当使用来源之一(手术后预防)的指南根据已发表的证据制定并实施,并在第二个观察期评估了对处方模式的影响。结果:患者在54.6%的住院天数内接受全身性抗生素治疗。为疑似感染或证实感染而开的抗生素通常比预期持续时间延长1-2天。预防占所有给予全身性抗生素的28%,术后预防占所有暴露天数的14.6%。文献检索几乎没有发现支持这种做法的证据。在引入旨在将手术预防限制为术前单剂量的新指南后,手术后预防率从所有暴露日的14.6%下降到11.2%,同时总暴露率从所有住院日的54.6%显著下降到50.2%。结论:发现了抗生素使用不当的几个来源。这些包括手术后未能停止治疗和延长预防。新指南的实施减少了抗生素的使用。
{"title":"[Rational utilization of antibiotics in critically ill children].","authors":"J E Fischer,&nbsp;M Ramser,&nbsp;S Altermatt,&nbsp;D Nadal,&nbsp;K Waldvogel","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The high risks associated with untreated infection in critically ill newborns or children lower the threshold for prescription of antibiotic treatment. Inappropriate use of antibiotic therapy promotes the emergence of resistant strains. This study had three aims: to identify sources of inappropriate antibiotic utilisation, to develop revised guidelines and to implement changes.</p><p><strong>Methods: </strong>An observational study was performed in a tertiary, multidisciplinary, neonatal and paediatric intensive care unit (PICU) of a university teaching hospital during a 7-month period (456 admissions). Guidelines addressing one of the identified sources of inappropriate utilisation (prophylaxis following surgery) were developed according to published evidence and implemented, and the effect on prescription patterns was assessed during a second observation period.</p><p><strong>Results: </strong>Patients received systemic antibiotics during 54.6% of all hospitalisation days. Antibiotics prescribed for suspected or proven infection were often continued 1-2 days beyond the intended duration. Prophylaxis accounted for 28% of all systemic antibiotics given, and postsurgical prophylaxis accounted for 14.6% of all exposure days. The literature search revealed little evidence to support this practice. After new guidelines were introduced with the aim of restricting surgical prophylaxis to a single dose prior to surgery, the rate of postsurgical prophylaxis dropped from 14.6 to 11.2% of all exposure days, accompanied by a significant decline in the overall exposure rate from 54.6 to 50.2% of all hospitalisation days.</p><p><strong>Conclusion: </strong>Several sources of inappropriate antibiotic utilisation were identified. These include failure to discontinue treatment and prolonged prophylaxis after surgery. Implementation of new guidelines reduced antibiotic utilisation.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21916780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The immature-to-total neutrophil ratio (IT ratio) is a sensitive indicator of sepsis after paediatric cardiopulmonary bypass. 未成熟中性粒细胞与总中性粒细胞比率(IT比率)是小儿体外循环术后脓毒症的敏感指标。
B Frey, S B Horton, T Duke, F Shann

Cardiopulmonary bypass (CPB) causes a systemic inflammatory response syndrome (SIRS) with activation of neutrophils (increased immature-to-total neutrophil ratio, IT ratio). Does an additional inflammatory response induced by sepsis further increase the IT ratio, so that it can still be used as an indicator of sepsis? In 160 children we analysed retrospectively the IT ratios from the day before CPB to the 10th day after the operation (controls). The 95% confidence limits of the controls were plotted against postoperative day and compared with the IT ratio courses in all children of a 4-year period who developed sepsis during the first 10 days after CPB. All septic children (n = 9) had IT ratios above the upper 95% confidence limits of the controls on the day of positive culture or on the following day. The IT ratio remains a sensitive indicator of sepsis even after CPB.

体外循环(CPB)引起全身炎症反应综合征(SIRS)与中性粒细胞的激活(增加未成熟与总中性粒细胞的比率,IT比率)。脓毒症引起的额外炎症反应是否会进一步增加IT比率,从而仍然可以作为脓毒症的指标?我们回顾性分析了160例患儿CPB术前至术后第10天的IT比率(对照组)。对照的95%置信限与术后天数进行对比,并与所有在CPB后前10天发生脓毒症的4年儿童的IT比率病程进行比较。所有脓毒症患儿(n = 9)在阳性培养当天或次日的IT比率均高于对照组的95%置信上限。即使在CPB后,IT比率仍然是脓毒症的敏感指标。
{"title":"The immature-to-total neutrophil ratio (IT ratio) is a sensitive indicator of sepsis after paediatric cardiopulmonary bypass.","authors":"B Frey,&nbsp;S B Horton,&nbsp;T Duke,&nbsp;F Shann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cardiopulmonary bypass (CPB) causes a systemic inflammatory response syndrome (SIRS) with activation of neutrophils (increased immature-to-total neutrophil ratio, IT ratio). Does an additional inflammatory response induced by sepsis further increase the IT ratio, so that it can still be used as an indicator of sepsis? In 160 children we analysed retrospectively the IT ratios from the day before CPB to the 10th day after the operation (controls). The 95% confidence limits of the controls were plotted against postoperative day and compared with the IT ratio courses in all children of a 4-year period who developed sepsis during the first 10 days after CPB. All septic children (n = 9) had IT ratios above the upper 95% confidence limits of the controls on the day of positive culture or on the following day. The IT ratio remains a sensitive indicator of sepsis even after CPB.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21916781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Schweizerische medizinische Wochenschrift
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1